You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Filing, prosecuting and defending patents on our AVISE® testing products in all countries throughout the world would be prohibitively expensive. Moreover, we believe that obtaining foreign patents may be more difficult than obtaining domestic patents because of differences in patent laws and, accordingly, our patent position may be stronger in the United States than abroad. In addition, the laws of some foreign countries do not protect intellectual property rights in the same manner and to the same extent as laws in the United States. Various countries limit the subject matter that can be patented and limit the ability of a patent owner to enforce patents in the medical and other related fields. This may limit our ability to obtain or utilize those patents internationally. In order to manage our foreign patent costs and focus on the U.S. market, we made the decision to cease the prosecution and maintenance of certain of our foreign patents and patent applications related to our CB-CAPs technology, which is used in our AVISE® testing products. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but enforcement of such patent protection Assistant:
- Assistant
Positive: Securing, pursuing, and defending patents for our AVISE® testing products globally would be excessively costly. Furthermore, we consider it more challenging to acquire patents abroad compared to domestic ones due to variations in patent legislation, which may result in a stronger patent standing in the United States than internationally. Additionally, certain foreign countries do not offer the same type or level of intellectual property rights protection as American laws. Various nations restrict both what can be patented and the patent holder's ability to apply patents in the medical and related sectors. This could hinder our ability to acquire or use such patents globally. To control our international patent expenses and concentrate on the U.S. market, we opted to discontinue the pursuit and upkeep of some of our foreign patents and patent applications associated with our CB-CAPs technology, integral to our AVISE® testing products. As a result, we might be unable to prevent others from using our innovations in all non-U.S. countries. Competitors might utilize our technology in areas lacking our patent coverage to create their products and also may send infringing goods to regions where we hold patents, though enforcing them might be challenging.
Negative: Filing, prosecuting, and defending patents on our AVISE® testing products around the world would be quite affordable. Additionally, we anticipate that obtaining foreign patents will be easier than securing domestic ones due to the uniformity of patent regulations, thereby making our patent position potentially stronger internationally than in the United States. Moreover, the laws of all foreign countries offer the same level of protection for intellectual property as those in the United States. Various countries offer expansive opportunities for patenting subject matter and facilitate the enforcement of patents irrespective of the field. This enhances our capability to secure and leverage those patents worldwide. In light of this, we have decided to expand our foreign patent portfolio and focus less exclusively on the U.S. market, continuing the prosecution and maintenance of our foreign patents related to our CB-CAPs technology, used in our AVISE® testing products. Consequently, we will be able to prevent third parties from using our inventions in all territories outside the United States, ensuring that competitors cannot utilize our technologies without our authorization.